GSA CAPITAL PARTNERS LLP - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q2 2023$12
-45.5%
18,077
-33.9%
0.00%
-50.0%
Q1 2023$22
-94.7%
27,338
-85.1%
0.00%
-96.2%
Q4 2022$416
-99.9%
183,857
-22.1%
0.05%
-13.3%
Q3 2022$456,000
-34.3%
236,120
+26.6%
0.06%
-42.3%
Q2 2022$694,000
-9.2%
186,480
+59.2%
0.10%
+1.0%
Q1 2022$764,000
+60.5%
117,109
+186.4%
0.10%
+71.7%
Q4 2021$476,000
+6.2%
40,885
+104.4%
0.06%
-20.0%
Q3 2020$448,00020,0000.08%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 1,147,040$13,363,0006.07%
Sands Capital Ventures, LLC 724,873$8,445,0001.25%
Quantum Private Wealth, LLC 145,718$1,697,0000.64%
Nantahala Capital Management 1,456,147$16,964,0000.60%
Artal Group S.A. 1,040,882$12,126,0000.33%
Alphabet Inc. 640,882$7,466,0000.18%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 500,000$5,825,0000.17%
TimesSquare Capital Management, LLC 659,100$7,679,0000.07%
GSA CAPITAL PARTNERS LLP 40,885$476,0000.06%
Virtus ETF Advisers LLC 11,519$134,0000.05%
View complete list of TAYSHA GENE THERAPIES INC shareholders